Arca
Skip to content
Tools
Tools

-ciclib

A CDK inhibitor, blocking the cyclin-dependent kinases that move cells through division; palbociclib, ribociclib and abemaciclib treat breast cancer.

  • Drugs ending in -ciclib: 35
  • Approved somewhere: 4
  • With a US drug page: 4

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-ciclib
Class
Drugs that block cyclin-dependent kinases (CDKs)
Most common targets
CDK4 (6), CDK1 (5), CDK2 (4), CDK9 (4), CDK6 (3), CDK5 (2), CDK7 (2), CCND1, CDK6 (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -ciclib, matched by spelling; those with a US drug page link to it.
Acts on
AbemaciclibApprovedCDK4, CDK6Cyclin-dependent kinase 4 inhibitor
PalbociclibApprovedCCND1, CDK6, CCND1, CDK4CDK6/cyclin D1 inhibitor
RibociclibApprovedCDK4, CDK6Cyclin-dependent kinase 4 inhibitor
TrilaciclibApprovedCDK4, CDK6Cyclin-dependent kinase 4 inhibitor
DalpiciclibPhase 3——
DinaciclibPhase 3CDK1, CDK2, CDK5, CDK9Cyclin-dependent kinase 1 inhibitor
LerociclibPhase 3——
AsnuciclibPhase 2——
AtirmociclibPhase 2——
CrozbaciclibPhase 2——
CulmerciclibPhase 2——
EbvaciclibPhase 2——
EciruciclibPhase 2——
FovinaciclibPhase 2——
InixaciclibPhase 2——
MilciclibPhase 2CDK1, CDK2, CDK4, NTRK1Cyclin-dependent kinase 1 inhibitor
MocaciclibPhase 2——
NarazaciclibPhase 2——
RoniciclibPhase 2Cyclin-dependent kinaseCyclin-dependent kinase inhibitor
SeliciclibPhase 2CDK2, CDK7, CDK9, CDK1 and 1 moreCyclin-dependent kinase 2 inhibitor
TacaciclibPhase 2——
TambiciclibPhase 2——
TibremciclibPhase 2——
UlecaciclibPhase 2——
ZemirciclibPhase 2——
AtuveciclibPhase 1——
AvotaciclibPhase 1——
BriciclibPhase 1CCND1G1/S-specific cyclin D1 inhibitor
CertociclibPhase 1——
EnitociclibPhase 1——
IstisociclibPhase 1——
TegtociclibPhase 1——
VoruciclibPhase 1CDK4Cyclin-dependent kinase 4 inhibitor
ZotiraciclibPhase 1CDK1, CDK2, CDK7, CDK9 and 2 moreCyclin-dependent kinase 1 inhibitor
Riviciclib—CDK1, CDK4, CDK9Cyclin-dependent kinase 1 inhibitor

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.